Not checked for notices yet.
Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial
Antoine Monsel, Caroline Hauw-Berlemont, Miryam Mebarki and 28 more
Critical Care · 2022
doi:10.1186/s13054-022-03930-4
Cited by papers we hold 4
- Deep insight into cytokine storm: from pathogenesis to treatment · 2025No notice
- Endothelial cell dynamics in sepsis-induced acute lung injury and acute respiratory distress syndrome: pathogenesis and therapeutic implications · 2024No notice
- Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications · 2022No notice
- Nebulized exosomes derived from allogenic adipose tissue mesenchymal stromal cells in patients with severe COVID-19: a pilot study · 2022No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.